2024-08-01 2025-07-31 2025-07-31 false 12473029 LIME INTERNATIONAL HEALTH LIMITED 2026-04-22 false iso4217:GBP xbrli:pure 12473029 2024-07-31 12473029 2025-07-31 12473029 2024-08-01 2025-07-31 12473029 2023-07-31 12473029 2024-07-31 12473029 2023-08-01 2024-07-31 12473029 bus:SmallEntities 2024-08-01 2025-07-31 12473029 bus:AuditExempt-NoAccountantsReport 2024-08-01 2025-07-31 12473029 bus:AbridgedAccounts 2024-08-01 2025-07-31 12473029 bus:PrivateLimitedCompanyLtd 2024-08-01 2025-07-31 12473029 core:WithinOneYear 2025-07-31 12473029 core:AfterOneYear 2025-07-31 12473029 core:WithinOneYear 2024-07-31 12473029 core:AfterOneYear 2024-07-31 12473029 core:ShareCapital 2025-07-31 12473029 core:SharePremium 2025-07-31 12473029 core:RevaluationReserve 2025-07-31 12473029 core:OtherReservesSubtotal 2025-07-31 12473029 core:RetainedEarningsAccumulatedLosses 2025-07-31 12473029 core:ShareCapital 2024-07-31 12473029 core:SharePremium 2024-07-31 12473029 core:RevaluationReserve 2024-07-31 12473029 core:OtherReservesSubtotal 2024-07-31 12473029 core:RetainedEarningsAccumulatedLosses 2024-07-31 12473029 core:LandBuildings 2025-07-31 12473029 core:PlantMachinery 2025-07-31 12473029 core:Vehicles 2025-07-31 12473029 core:FurnitureFittings 2025-07-31 12473029 core:OfficeEquipment 2025-07-31 12473029 core:NetGoodwill 2025-07-31 12473029 core:IntangibleAssetsOtherThanGoodwill 2025-07-31 12473029 core:ListedExchangeTraded 2025-07-31 12473029 core:UnlistedNon-exchangeTraded 2025-07-31 12473029 core:LandBuildings 2024-07-31 12473029 core:PlantMachinery 2024-07-31 12473029 core:Vehicles 2024-07-31 12473029 core:FurnitureFittings 2024-07-31 12473029 core:OfficeEquipment 2024-07-31 12473029 core:NetGoodwill 2024-07-31 12473029 core:IntangibleAssetsOtherThanGoodwill 2024-07-31 12473029 core:ListedExchangeTraded 2024-07-31 12473029 core:UnlistedNon-exchangeTraded 2024-07-31 12473029 core:LandBuildings 2024-08-01 2025-07-31 12473029 core:PlantMachinery 2024-08-01 2025-07-31 12473029 core:Vehicles 2024-08-01 2025-07-31 12473029 core:FurnitureFittings 2024-08-01 2025-07-31 12473029 core:OfficeEquipment 2024-08-01 2025-07-31 12473029 core:NetGoodwill 2024-08-01 2025-07-31 12473029 core:IntangibleAssetsOtherThanGoodwill 2024-08-01 2025-07-31 12473029 core:ListedExchangeTraded 2024-08-01 2025-07-31 12473029 core:UnlistedNon-exchangeTraded 2024-08-01 2025-07-31 12473029 core:MoreThanFiveYears 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments 2025-07-31 12473029 core:Non-currentFinancialInstruments 2024-07-31 12473029 dpl:CostSales 2024-08-01 2025-07-31 12473029 dpl:DistributionCosts 2024-08-01 2025-07-31 12473029 core:LandBuildings 2024-08-01 2025-07-31 12473029 core:PlantMachinery 2024-08-01 2025-07-31 12473029 core:Vehicles 2024-08-01 2025-07-31 12473029 core:FurnitureFittings 2024-08-01 2025-07-31 12473029 core:OfficeEquipment 2024-08-01 2025-07-31 12473029 dpl:AdministrativeExpenses 2024-08-01 2025-07-31 12473029 core:NetGoodwill 2024-08-01 2025-07-31 12473029 core:IntangibleAssetsOtherThanGoodwill 2024-08-01 2025-07-31 12473029 dpl:GroupUndertakings 2024-08-01 2025-07-31 12473029 dpl:ParticipatingInterests 2024-08-01 2025-07-31 12473029 dpl:GroupUndertakings core:ListedExchangeTraded 2024-08-01 2025-07-31 12473029 core:ListedExchangeTraded 2024-08-01 2025-07-31 12473029 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-08-01 2025-07-31 12473029 core:UnlistedNon-exchangeTraded 2024-08-01 2025-07-31 12473029 dpl:CostSales 2023-08-01 2024-07-31 12473029 dpl:DistributionCosts 2023-08-01 2024-07-31 12473029 core:LandBuildings 2023-08-01 2024-07-31 12473029 core:PlantMachinery 2023-08-01 2024-07-31 12473029 core:Vehicles 2023-08-01 2024-07-31 12473029 core:FurnitureFittings 2023-08-01 2024-07-31 12473029 core:OfficeEquipment 2023-08-01 2024-07-31 12473029 dpl:AdministrativeExpenses 2023-08-01 2024-07-31 12473029 core:NetGoodwill 2023-08-01 2024-07-31 12473029 core:IntangibleAssetsOtherThanGoodwill 2023-08-01 2024-07-31 12473029 dpl:GroupUndertakings 2023-08-01 2024-07-31 12473029 dpl:ParticipatingInterests 2023-08-01 2024-07-31 12473029 dpl:GroupUndertakings core:ListedExchangeTraded 2023-08-01 2024-07-31 12473029 core:ListedExchangeTraded 2023-08-01 2024-07-31 12473029 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-08-01 2024-07-31 12473029 core:UnlistedNon-exchangeTraded 2023-08-01 2024-07-31 12473029 core:NetGoodwill 2025-07-31 12473029 core:IntangibleAssetsOtherThanGoodwill 2025-07-31 12473029 core:LandBuildings 2025-07-31 12473029 core:PlantMachinery 2025-07-31 12473029 core:Vehicles 2025-07-31 12473029 core:FurnitureFittings 2025-07-31 12473029 core:OfficeEquipment 2025-07-31 12473029 core:AfterOneYear 2025-07-31 12473029 core:WithinOneYear 2025-07-31 12473029 core:ListedExchangeTraded 2025-07-31 12473029 core:UnlistedNon-exchangeTraded 2025-07-31 12473029 core:ShareCapital 2025-07-31 12473029 core:SharePremium 2025-07-31 12473029 core:RevaluationReserve 2025-07-31 12473029 core:OtherReservesSubtotal 2025-07-31 12473029 core:RetainedEarningsAccumulatedLosses 2025-07-31 12473029 core:NetGoodwill 2024-07-31 12473029 core:IntangibleAssetsOtherThanGoodwill 2024-07-31 12473029 core:LandBuildings 2024-07-31 12473029 core:PlantMachinery 2024-07-31 12473029 core:Vehicles 2024-07-31 12473029 core:FurnitureFittings 2024-07-31 12473029 core:OfficeEquipment 2024-07-31 12473029 core:AfterOneYear 2024-07-31 12473029 core:WithinOneYear 2024-07-31 12473029 core:ListedExchangeTraded 2024-07-31 12473029 core:UnlistedNon-exchangeTraded 2024-07-31 12473029 core:ShareCapital 2024-07-31 12473029 core:SharePremium 2024-07-31 12473029 core:RevaluationReserve 2024-07-31 12473029 core:OtherReservesSubtotal 2024-07-31 12473029 core:RetainedEarningsAccumulatedLosses 2024-07-31 12473029 core:NetGoodwill 2023-07-31 12473029 core:IntangibleAssetsOtherThanGoodwill 2023-07-31 12473029 core:LandBuildings 2023-07-31 12473029 core:PlantMachinery 2023-07-31 12473029 core:Vehicles 2023-07-31 12473029 core:FurnitureFittings 2023-07-31 12473029 core:OfficeEquipment 2023-07-31 12473029 core:AfterOneYear 2023-07-31 12473029 core:WithinOneYear 2023-07-31 12473029 core:ListedExchangeTraded 2023-07-31 12473029 core:UnlistedNon-exchangeTraded 2023-07-31 12473029 core:ShareCapital 2023-07-31 12473029 core:SharePremium 2023-07-31 12473029 core:RevaluationReserve 2023-07-31 12473029 core:OtherReservesSubtotal 2023-07-31 12473029 core:RetainedEarningsAccumulatedLosses 2023-07-31 12473029 core:AfterOneYear 2024-08-01 2025-07-31 12473029 core:WithinOneYear 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments core:CostValuation 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-08-01 2025-07-31 12473029 core:Non-currentFinancialInstruments core:CostValuation 2025-07-31 12473029 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2025-07-31 12473029 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2025-07-31 12473029 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2025-07-31 12473029 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2025-07-31 12473029 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2025-07-31 12473029 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2025-07-31 12473029 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2025-07-31 12473029 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2025-07-31 12473029 core:Non-currentFinancialInstruments core:CostValuation 2024-07-31 12473029 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-07-31 12473029 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-07-31 12473029 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-07-31 12473029 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-07-31 12473029 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-07-31 12473029 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-07-31 12473029 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-07-31 12473029 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-07-31 12473029 bus:Director1 2024-08-01 2025-07-31

LIME INTERNATIONAL HEALTH LIMITED

Registered Number
12473029
(England and Wales)

Unaudited Financial Statements for the Year ended
31 July 2025

LIME INTERNATIONAL HEALTH LIMITED
Company Information
for the year from 1 August 2024 to 31 July 2025

Director | WILLIAMS, Shaun Phillip

Registered Address | Level 30, Leadenhall Building
| 122 Leadenhall Street
| London
| EC3V 4AB

Registered Number | 12473029 (England and Wales)

LIME INTERNATIONAL HEALTH LIMITED
Balance Sheet as at
31 July 2025

| Notes | 2025 |  | 2024
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | - |  |  |  | 4,582
|  |  |  | - |  |  |  | 4,582
Current assets |  |  |  |  |  |  |  |
Debtors |  | 1,055 |  |  |  | 15,226 |  |
Cash at bank and on hand |  | 1 |  |  |  | 3 |  |
|  | 1,056 |  |  |  | 15,229 |  |
Creditors amounts falling due within one year |  | (389,848) |  |  |  | (414,700) |  |
Net current assets (liabilities) |  |  |  | (388,792) |  |  |  | (399,471)
Total assets less current liabilities |  |  |  | (388,792) |  |  |  | (394,889)
Net assets |  |  |  | (388,792) |  |  |  | (394,889)
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 1,000 |  |  |  | 1,000
Profit and loss account |  |  |  | (389,792) |  |  |  | (395,889)
Shareholders' funds |  |  |  | (388,792) |  |  |  | (394,889)

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.
- The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A).

The financial statements were approved and authorised for issue by the Director on 22 April 2026, and are signed on its behalf by:
WILLIAMS, Shaun Phillip Director Registered Company No. 12473029

LIME INTERNATIONAL HEALTH LIMITED
Notes to the Financial Statements
for the year ended 31 July 2025

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

| Revenue from sale of goods
--- | ---
| Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Tangible fixed assets and depreciation
--- | ---
| All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

|  | Straight line (years)
| Office Equipment | 3

2. | Average number of employees
--- | ---

|  | 2025 |  | 2024
| Average number of employees during the year | 1 |  | 1

3. | Tangible fixed assets
--- | ---

|  | Total
--- | --- | ---
|  | £
| Cost or valuation
| At 01 August 24 | 4,582
| Disposals | (4,582)
| Net book value
| At 31 July 25 | -
| At 31 July 24 | 4,582

4. | Related party transactions
--- | ---
| There is a debtor balance of £1020 with Lime Corporate Services Ltd, £1000 of which represents opening share capital of which 100% is owned by that company. (£1020 debtor at end of prior period). There is a creditor balance of £179500 with Lime Global Ltd (£60000 creditor at the end of the prior period). There is a creditor balance of £35 with Lime International Ltd (£35 creditor at the end of the prior period). There is a creditor balance of £206687 with Lime International Partners Ltd (£327021 creditor at the end of the prior period). There is a debtor balance of £35 with Lime International APAC Ltd (£35 debtor at the end of the prior period). £263 of the IT Software and Consumables costs were recharges from Lime International Partners Ltd (£128996 prior period).

5. | Controlling party
--- | ---
| The ultimate controlling party is Lime Global Ltd.